HONG KONG: Chinese biotech startup Shanghai Junshi Biosciences Co Ltd soared more than 22% in its Hong Kong debut yesterday after raising US$394mil in its initial public offering (IPO), a rare strong showing by a biotech company in the Asian financial hub.
Shares of Junshi Biosciences opened at HK$23.50 (US$3) and closed at HK$23.7, about 22% above the IPO price of HK$19.38.
